Non-drug therapies for cognitive impairment

The review considers basic methods for non-drug correction of cognitive disorders, as well as a combined approach, including the use of drugs and cognitive-motor training in the rehabilitation of patients with impaired cognitive functions. The authors present their own data on the efficiency of non-drug therapies in patients with Alzheimer’s disease.

non-drug treatments, non-pharmacological treatments, basic therapy, NMDA receptor antagonists, akatinol memantine, moderate cognitive impairment, vascular cognitive impairment, Alzheimer’s disease, cognitive training, cognitive stimulation, cognitive-motor training, physical exercises, psychotherapeutic treatment, meditation, yoga, sleep normalization, music therapy, art therapy, diet

1. Mendelevich EG. Cognitive and non-cognitive neuropsychiatric disorders in dementia and methods of their correction. Nevrologiya, Neiropsikhiatriya, Psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2017;9(2):65-70 (In Russ.). doi: 10.14412/2074-2711-2017-2-65-70

2. Naumenko AA, Vakhnina NV. Alzheimer's disease under the mask of stroke. Nevrologiya, Neiropsikhiatriya, Psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2016;8(2):100-6 (In Russ.). doi: 10.14412/2074-2711-2016-2-100-106

3. Naumenko AA, Gromova DO, Trofimova NV, Preobrazhenskaya IS. Alzheimer’s disease: Diagnosis and treatment. Nevrologiya, Neiropsikhiatriya, Psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2016;8(4):91-7 (In Russ.). doi: 10.14412/2074-2711-2016-4-91-97

4. Wilson RS, Scherr PA, Schneider JA, et al. Relation of cognitive activity to risk of developing Alzheimer disease. Neurology. 2007;69: 1911-20. doi: 10.1212/01.wnl.0000271087.67782.cb

5. Starchina YuA. Cognitive impairment without dementia: A current view of the problem. Nevrologiya, Neiropsikhiatriya, Psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2017;9(2):71-6 (In Russ.). doi: 10.14412/2074-2711-2017-2-71-76

6. Bherer L, Kramer AF, Peterson MS, et al. Testing the limits of cognitive plasticity in older adults: application to attentional control. Acta Psychol. 2006;123:261-78. doi: 10.1016/j.actpsy.2006.01.005

7. Kolb B, Gibb R. Principles of neuroplasticity and behavior. In: Stuss D, Winocur G, Robertson I, eds. Cognitive Neurorehabilitation: Evidence and Application. 2nd ed. NY, USA: Cambridge University Press, 2008. P. 6-21.

8. Bherer L, Kramer AF, Peterson MS, et al. Training effects on dual-task performance: are there age-related differences in plasticity of attentional control? Psychol Aging. 2005;20:695- 709. doi: 10.1037/0882-7974.20.4.695

9. Bherer L, Kramer AF, Peterson M, et al. Transfer effects in task-set cost and dual-task cost after dual-task training in older and younger adults: further evidence for cognitive plasticity in attentional control in late adulthood. Exp Aging Res. 2008;34:1-32. doi: 10.1080/03610730802070068

10. Bherer L. Cognitive plasticity in older adults: effects of cognitive training and physical exercise. PERFORM Centre and Psychology Department, Concordia University, Montreal, Quebec, Canada. Ann N Y Acad Sci. 2015; 1337:1-6. doi: 10.1111/nyas.12682

11. Koberskaya NN, Tabeeva GR. The modern concept of cognitive reserve. Nevrologiya, Neiropsikhiatriya, Psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(1):96-102 (In Russ.). doi: 10.14412/2074-2711-2019-1-96-102

12. Brickman AM, Siedlecki KL, Stern Y. Cognitive and Brain reserve. In: Depp CA, Jeste D, eds. Successful Cognitive and Emotional Aging. Arlington, USA: American Psychiatric Publishing, Inc.; 2010. P. 157-72.

13. Stern Y, Habeck C, Moeller J, et al. Brain networks associated with cognitive reserve in healthy young and old adults. Cereb Cortex. 2005;15(4):394-402. doi: 10.1093/cercor/bhh142

14. Rodakowski J, Saghafi E, Butters MA, Skidmore ER. Non-pharmacological interventions for adults with mild cognitive impairment and early stage dementia: An updated scoping review. Mol Aspects Med. 2015;43-44:38-53. doi: 10.1016/j.mam.2015.06.003:1-16

15. Sitzer DI, Twamley EW, Jeste DV. Cognitive training in Alzheimer`s disease: a meta-analysis of the literature. Acta Psychiatry Scand. 2006; 114(2):75-90. doi: 10.1111/j.1600-0447.2006.00789.x

16. Kawashima R. Mental Exercises for Cognitive Function: Clinical Evidence. J Prev Med Public Health. 2013;46:522-7. doi: 10.3961/jpmph.2013.46.S.S22

17. Belleville S, Bherer L. Biomarkers of cognitive training effects in aging. Curr Transl Geriatric Exp Gerontol Rep. 2012;1:104-10. doi: 10.1007/s13670-012-0014-5

18. Erickson KI, Colcombe SJ, Wadhwa R, et al. Training-induced plasticity in older adults: effects of training on hemispheric asymmetry. Neurobiol Aging. 2007;28:272-83. doi: 10.1016/j.neurobiolaging.2005.12.012

19. Van Paasschen J, Clare L, Yuen KS, et al. Cognitive rehabilitation changes memory-related brain activity in people with Alzheimer disease. Neurorehabil Neural Repair. 2013;27(5): 448-59. doi: 10.1177/1545968312471902

20. Boripuntakul S, Kothan S, Methapatara P, et al. Short-Term Effects of Cognitive Training Program for Individuals with Amnestic Mild Cognitive Impairment: A Pilot Study. 2nd ed. Taylor & Francis, UK; 2012. P. 138-49.

21. Palmer K, Wang H-X, Backman L, et al. Differential evolution of cognitive impairment in non-demented older persons. Am J Psychiatry. 2002;159:436-42. doi: 10.1176/appi.ajp.159.3.436

22. Martin M, Clare L, Altgassen AM, et al. Cognition-based interventions for healthy older people and people with mild cognitive impairment. Cochrane Database Syst Rev. 2011;1: CD006220. doi: 10.1002/14651858.CD006 220.pub2

23. Mendelevich EG. Alzheimer's disease: some pharmacological and non-pharmacological approaches to correcting neuropsychiatric disorders. Nevrologiya, Neiropsikhiatriya, Psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2018;10(3):129-34 (In Russ.). doi: 10.14412/2074-2711-2018-3-129-134

24. Patton D. Reality orientation: its use and effectiveness within older person mental health care. J Clin Nurs. 2006 Nov;15(11):1440-9. doi: 10.1111/j.1365-2702.2005.01450.x

25. Spector A, Orrell M, Davies S, Woods B. WITHDRAWN: Reality orientation for dementia. Cochrane Database Syst Rev. 2007 Jul 18;(3): CD001119.

26. Cruz TJP, Sa SPC, Lindolpho MC, Caldas CP. Cognitive stimulation for older people with Alzheimer’s disease performed by the caregiver. Rev Bras Inform. 2015;68(4):450-6. doi: 10.1590/0034-7167.2015680319i

27. Yates L, Orrell M, Spector A, Ortega V. Service users’ involvement in the development of individual Cognitive Stimulation Therapy (iCST) for dementia: a qualitative study. BMC Geriatrics. 2015;15(4):1-10. doi: 10.1186/s12877-015-0004-5

28. Woods B, Aguirre E, Spector AE, Orrell M. Cognitive stimulation to improve cognitive functioning in people with dementia. Cochrane Database Syst Rev. 2012;2:CD005562. doi: 10.1002/14651858.CD005562.pub2

29. Schmidt W, Endres M, Dimeo F, Jungehulsing GJ. Train the vessel, gain the brain: physical activity and vessel function and the impact on stroke prevention and outcome in cerebrovascular disease. Cerebrovasc Dis. 2013; 35(4):303-12. doi: 10.1159/000347061

30. Colcombe S, Kramer AF. Fitness effects on the cognitive function of older adults a metaanalytic study. Psychol Sci. 2003;14(2):125-30. doi: 10.1111/1467-9280.t01-1-01430

31. Young J, Angevaren M, Rusted J, Tabet N. Aerobic exercise to improve cognitive function in older people without known cognitive impairment. Cochrane Database Syst Rev. 2015; 4:CD005381. doi: 10.1002/14651858.CD005381.pub4

32. Baker L, Frank L, Foster-Schubert K, et al. Effects of Aerobic Exercise on Mild Cognitive Impairment: A Controlled Trial. Arch Neurol. 2010;67(1):71-9. doi: 10.1001/archneurol.2009.307

33. Suzuki T, Shimada H, Makizako H, et al. Effects of multicomponent exercise on cognitive function in older adults with amnestic mild cognitive impairment: a randomized controlled trial. BMC Neurol. 2012;12:128. doi: 10.1186/1471-2377-12-128

34. Naumenko AA, Preobrazhenskaya IS. Cognitive and motor training for patients with moderate cognitive impairment and mild dementia. Nevrologiya, Neiropsikhiatriya, Psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2018;10(4):81-7 (In Russ.). doi: 10.14412/2074-2711-2018-4-81-87

35. Volel BA, Petelin DS, Akhapkin RV, Malyutina AA. Cognitive impairment in anxiety disorders. Nevrologiya, Neiropsikhiatriya, Psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2018;10(1):78-82 (In Russ.). doi: 10.14412/2074-2711-2018-1-78-82

36. Stanley MA, Calleo J, Bush A, et al. The peaceful mind program: a pilot test of a cognitive-behavioral therapy-based intervention for anxious patients with dementia. Am J Geriatric Psychiatry 2013;21(7):696-708. doi: 10.1016/ j.jagp.2013.01.007

37. Wells RE, Yeh GY, Kerr CE, et al. Meditation’s impact on default mode network and hippocampus in mild cognitive impairment: a pilot study. Neurosci Lett. 2013;556:15-9. doi: 10.1016/j.neulet.2013.10.001

38. Hogan S. Healing Arts: The history of art therapy. London: Jessica Kingsley Publishers; 2001.

39. Kabat-Zinn J. Full Catastrophe Living: Using the Wisdom of Your Body and Mind to Face Stress, Pain, and Illness. New York: Random House; 1990.

40. Lazar SW, Bush G, Gollub RL, et al. Functional brain mapping of the relaxation response and meditation. Neuro Report. 2000;11:1581-5. doi: 10.1097/00001756-200005150-00042

41. Luders E, Toga AW, Lepore N, et al. The underlying anatomical correlates of longterm meditation: Larger hippocampal and frontal volumes of gray matter. Neuroimaging. 2009;45:672-8. doi: 10.1016/j.neuroimage.2008.12.061

42. Wells RE, Kerr CE, Wolkin J, et al. Meditation for adults with mild cognitive impairment: a pilot randomized trial. J Am Geriatr Soc. 2013;61(4):642-5. doi: 10.1111/jgs.12179

43. Bogolepova AN. Sleep disorders and Alzheimer’s disease. Nevrologiya, Neiropsikhiatriya, Psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2018;10(1):74-7 (In Russ.). doi: 10.14412/2074-2711-2018-1-74-77

44. Alfano CA, Zakem AH, Costa NM, et al. Sleep problems and their relation to cognitive factors, anxiety, and depressive symptoms in children and adolescents. Depress Anxiety. 2009; 26:503-12. doi: 10.1002/da.20443

45. Diekelmann S. Sleep for cognitive enhancement. Front Syst Neurosci. 2014;8:46. doi: 10.3389/fnsys.2014.00046

46. Goder R, Baier PC, Beith B, et al. Effects of transcranial direct current stimulation during sleep on memory performance in patients with schizophrenia. Schizophrenia Res. 2013;144:153-4. doi: 10.1016/j.schres.2012.12.014

47. Rasch B, Born J. About sleep’s role in memory. Physiol Rev. 2013;93:681-766. doi: 10.1152/physrev.00032.2012

48. Wiks A, Kumar K, Anand K. Non Pharmacological Cognitive Enhancers – Current Perspectives. J Clin Diagnost Res. 2015 Jul;9(7):VE01-VE06.

49. Vink AC, Bruinsma MS, Scholten RJPM. Music therapy for people with dementia. Cochrane Database System Rev. 2004;3:CD003477. doi: 10.1002/14651858.CD003477.pub2

50. Wan CY, Schlaug G. Music making as a tool for promoting brain plasticity across the life span. Neuroscientist: Rev J Bring Neurobiol Neurol Psychiatry. 2010;16(5):566-77. doi: 10.1177/1073858410377805

51. Chu H, Yang CY, Lin Y, et al. The impact of group music therapy on depression and cognition in elderly persons with dementia: a randomized controlled study. Biol Res Nurs. 2014; 16:209-17. doi: 10.1177/1099800413485410

52. Robertson-Gillam K. Hearing the voice of the elderly: The potential for choir work to reduce depression and meet spiritual needs. In: McKinley E, ed. Ageing, Disability and Spirituality: addressing the challenge of disability in later life. London: Jessica Kingsley; 2008.

53. Chancellor B, Duncan A, Chatterjee A. Art Therapy for Alzheimer’s Disease and Other Dementias. J Alzheimer’s Dis. 2014;39:1-11. doi: 10.3233/JAD-131295

54. Stuckey HL, Nobel J. The connection between art, healing, and public health: A review of current literature. Am J Public Health. 2010;100: 254-63. doi: 10.2105/AJPH.2008.156497

55. Geue K, Goetze H, Buttstaedt M, et al. An overview of art therapy interventions for cancer patients and the results of research. Complement Ther Med. 2010;18:160-70. doi: 10.1016/j.ctim.2010.04.001

56. Lomo T. The discovery of long-term potentiation. Philos Trans R Soc Lond B Biol Sci. 2003; 358(1432):617-20. doi: 10.1098/rstb.2002.1226

57. Kahn-Denis KB. Art therapy with geriatric dementia clients. Art Ther J Am Art Ther Assoc. 1997;14:194-9. doi: 10.1080/07421656.1987.10759281

58. Peisah C, Lawrence G, Reutens S. Creative solutions for severe dementia with BPSD: A case of art therapy used in an inpatient and residential care setting. Int Psychogeriatric. 2011;23:1011-3. doi: 10.1017/S1041610211000457

59. Safar LT, Press DZ. Art and the brain: Effects of dementia on art production in art therapy. Art Therapy. 2011;28:96-103. doi: 10.1080/07421656.2011.599734

60. Stewart EG. Art therapy and neuroscience blend: Working with patients who have dementia. Art Ther J Am Art Ther Assoc. 2004;21:148-55. doi: 10.1080/07421656.2004.10129499

61. Wald J. Art therapy and brain dysfunction in a patient with a dementing illness. Art Ther J Am Art Ther Assoc. 1993;10:88-95. doi: 10.1080/07421656.1993.10758987

62. Stallings JW, Emporia KS. (2010) Collage as a therapeutic modality for reminiscence in patients with dementia. Art Ther J Am Art Ther Assoc. 2010;27:136-40. doi: 10.1080/07421656.2010.10129667

63. Hattori H, Hattori C, Hokao C, et al. Controlled study on the cognitive and psychological effect of coloring and drawing in mild Alzheimer’s disease patients. Geriatr Gerontol Int. 2011;11:431-7. doi: 10.1111/j.1447-0594.2011.00698.x

64. Bayer-Carter JL, Green PS, Montine TJ, et al. Diet intervention and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment. Arch Neurol. 2011 Jun;68(6):743-52. doi: 10.1001/archneurol.2011.125

65. Morris MC, Evans DA, Tangney CC, et al. Associations of vegetable and fruit consumption with age-related cognitive change. Neurology. 2006;67:1370-6. doi: 10.1212/01.wnl.0000240224.38978.d8

66. Parfenov VA, Zakharov VV, Preobrazhenskaya IS. Kognitivnye rasstroistva [Cognitive disorders]. Moscow: Remedium Grupp; 2014. P. 1-106 (In Russ.).

67. Del Parigi A, Panza F, Capurso C, Solfrizzi V. Nutritional factors, cognitive decline, and dementia. Brain Res Bull. 2006;69:1-19. doi: 10.1016/j.brainresbull.2005.09.020

68. Skoog I, Gustafson D. Clinical trials for primary prevention in dementia. In: Rockwood K, Gauthier S, eds. Dementia therapeutic research. London, New York: Taylor a Francis, 2006. P. 189-212.

69. Abduraimova SK, Zakharov VV, Kabaeva AR. Cognitive, emotional, and behavioral disorders in hypertensive patients. Nevrologiya, Neiropsikhiatriya, Psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2018;10(4): 116-22 (In Russ.). doi: 10.14412/2074-2711-2018-4-116-122

70. Voskresenskaya ON, Zakharova NB, Tarasova YuS, et al. Possible mechanisms of cognitive dysfunction in patients with chronic forms of cerebrovascular diseases. Nevrologiya, Neiropsikhiatriya, Psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2018;10(1):32-6 (In Russ.). doi: 10.14412/2074-2711-2018-1- 32-36

71. Zakharov VV, Vakhnina NV. Vascular and neurodegenerative cognitive impairments: a clinical case report. Nevrologiya, Neiropsikhiatriya, Psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2016;8(2): 55-61 (In Russ.). doi: 10.14412/2074-2711-2016-2-55-61

72. Ostroumova OD, Karavashkina EA. Combination therapy for cognitive and emotional impairments in patients with arterial hypertension. Nevrologiya, Neiropsikhiatriya, Psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2017;9(1):84-9 (In Russ.). doi: 10.14412/2074-2711-2017-1-84-89

73. Baskys A, Hou AC. Vascular dementia: pharmacological treatment approaches and perspectives. Clin Intervent Aging. 2007;2(3):327-35.

74. Butefisch CM. Plasticity in the human cerebral cortex: lessons from the normal brain and from stroke. Neuroscientist. 2004;10:163-73. doi: 10.1177/1073858403262152

75. Zakharov VV. Glutamatergic therapy in the recovery period after ischemic stroke. Effektivnaya Farmakoterapiya. Nevrologiya. 2014;42(4):6-14 (In Russ.).

76. Parson CG, Danysz W, Quack G. Memantine is a clinically well tolerated N-Methyl-D-aspartate (NMDA) receptor antagonist – a review of preclinical data. Neuropharmacology. 1999;38:735-67. doi: 10.1016/S0028-3908(99)00019-2

77. Thomas SJ, Grossberg GT. Memantine: a review of studies into its safety and efficacy in treating Alzheimer’s disease and other dementias. Clin Intervent Aging. 2009;4:367-77. doi: 10.2147/CIA.S6666

78. Sastre A, Sheriff F, McShane R. Memantine for dementia. Cochrane Database Syst Rev. 2005; 3:CD003154. doi: 10.1002/14651858. CD003154. pub.4

79. Orgogozo JM, Rigaud AS, St?ffler A, et al. Efficacy and Safety of Memantine in Patients With Mild to Moderate Vascular Dementia: A Randomized, Placebo-Controlled Trial (MMM 300). Stroke. 2002;33(7):1834-9. doi: 10.1161/01.STR.0000020094.08790.49

80. Wilcock G, Mö bius HJ, Stö ffler A. A double-blind, placebo-controlled multicenter study of Memantine in mild to moderate vascular dementia (MMM500). Int Clin Psychopharmacol. 2002;17(6):297-305. doi: 10.1097/00004850-200211000-00005

81. Zakharov VV, Vakhnina NV. Cognitive impairment in depression. Effektivnaya farmakoterapiya. Nevrologiya i psikhiatriya. 2015;(1):18-27 (In Russ.).

82. Levin OS, Yunishchenko NA, Dudarova MA. The effectiveness of acatinol memantine with moderate cognitive impairment. Zhurnal Nevrologii i Psikhiatrii. 2009;(7):36-42 (In Russ.).

83. Yakhno NN, Preobrazhenskaya IS, Zakharov VV, Mkhitaryan EA. Efficacy of memantine in patients with non-degraded cognitive disorders. The results of a multicenter clinical observation. Nevrologicheskii Zhurnal. 2010;15(2):52-8 (In Russ.).

84. Zakharov VV, Vakhnina NV. Stroke and cognitive disorders. Nevrologiya, Neiropsikhiatriya, Psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2011;3(2):8-16 (In Russ.). doi: 10.14412/2074-2711-2011-141

85. Parfenov VA, Vakhnina NV, Nikitina LYu. Cognitive impairment after stroke and their treatment with memantine. Klinicheskaya Gerontologiya. 2005;11(8):49-52 (In Russ.).

86. Kleiser B, Diepers M, Geiger S, et al. Combined therapy with flunarizine and Memantine of experimental intracerebral hematoma in rats. Neurol Psych. 1995;3:219-24.